 Clovis Oncology, Inc. NASDAQ:CLVS Q1 2022 Earnings Conference Call May 4, 2022 8:30 AM ET Company Participants Anna Sussman - VP, IR and Corporate Communications Patrick Mahaffy - President and CEO Thomas Harding - Chief Scientific Officer Dan Muehl - CFO Conference Call Participants Charlie Ferranti - Goldman Sachs Operator Good morning. And welcome to the Clovis Oncology First Quarter 2022 Operating Results Conference Call. 